Headlines
-
Update for Pharmacists in Alfred’s path
Thursday | Mar 6 2025THE Pharmaceutical Benefits Scheme (PBS) has extended the Continued Dispensing Emergency Measure it put in place to help flood-affected people in Far North Queensland to include those who may be impacted by Tropical Cyclone Alfred in coming days.
-
NAPE interns join AdPha for free
Thursday | Mar 6 2025ADVANCED Pharmacy Australia (AdPha) has announced free membership for all interns enrolled in National Alliance for Pharmacy Education (NAPE) university internship programs.
-
Editor’s Choice: Natio Mother’s Day gifts that give twice
Thursday | Mar 6 2025NATIO is creating gift sets for Mother's Day, with $1 from every purchase going to Lighthouse Foundation to support its mission to end youth homelessness.
-
NSAIDs prevent dementia
Thursday | Mar 6 2025PEOPLE who use anti-inflammatory drugs over a long period of time may be at a lower risk of dementia regardless of the dosage, according to a Dutch study published in the Journal of the American Geriatrics Society.
-
CMO urges vaccinators to improve uptake
Wednesday | Mar 5 2025IN A letter to health professionals, Chief Medical Officer Professor Anthony Lawler expressed concern about declining influenza vaccine rates, urging vaccinators to focus on improving uptake as the flu season approaches.
-
AdPha welcomes IV fluid boost
Wednesday | Mar 5 2025HEALTH Minister Mark Butler has announced a $20 million government investment in increased local production of IV fluids in a move designed to end Australia's reliance on the product from overseas.
-
Travel telehealth and pharmacies team up
Wednesday | Mar 5 2025A NEW telehealth travel medicine service has launched in NSW, teaming up with pharmacies across the state to improve access to high-quality pre-travel healthcare.
-
Systems focus for WOD
Tuesday | Mar 4 2025WORLD Obesity Day (WOD) takes place today, with this year's theme shining a spotlight on the systems that shape our health: 'Changing systems.
-
Yindyamarra: AdPha’s vision for 2030
Tuesday | Mar 4 2025ADVANCED Pharmacy Australia (AdPha) has released its six-year strategic plan, with the patient at the heart of everything they do.
-
AD drug knocked back
Tuesday | Mar 4 2025The Therapeutic Goods Administration (TGA) has confirmed its initial decision from Oct 2024 not to register lecanemab in Australia for use as an amyloid-lowering therapy for the treatment of mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's dementia (early Alzheimer's disease).
